Alopexx
VC Fund
Concord, United States
Alopexx is a VC fund in Concord focused on Health Care and Therapeutics. Alopexx partners with innovative entrepreneurs to build successful new companies. We will in-license novel therapies or medical devices
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Alopexx invests in
Stages Alopexx invests in
Countries Alopexx invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daniel Vlock
|
|||
Investment Focus
Industry
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
- Health Diagnostics 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Daniel Vlock
Founder and CEO; Chief Medical Officer; Chief Medical Officer; CEO of Alopexx Pharmaceuticals
|
Founder and CEO; Chief Medical Officer; Chief Medical Officer; CEO of Alopexx Pharmaceuticals | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cognoptix
|
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.The company was founded in 2001 and headquarteredin Marlborough, Massachusetts. | $15M / Series D / Sep 30, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alopexx invest in?
Alopexx invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alopexx?
Public channels for Alopexx include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alopexx?
The team at Alopexx includes Daniel Vlock (Founder and CEO; Chief Medical Officer; Chief Medical Officer; CEO of Alopexx Pharmaceuticals). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
